ACTIVE

ICON Clinical Research Belgium

Export PDF

Financial year 2024 · Closed on 31/12/2024

Net result2,9 M €+68,8 %over 1 year
Revenue42,5 M €+35,6 %over 1 year
Equity13,6 M €+56,4 %over 1 year
Workforce331,4 ETP+37,7 %over 1 year

Identity

Source · BCE/KBO

ICON Clinical Research Belgium is a Private limited company incorporated in 1999. Its main activity is: Management consultancy activities. Its registered office is in Mechelen. It employs on average 331,4 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0467.032.927
Incorporation
08/10/1999
Legal form
Private limited company
Registered office
Kardinaal Mercierplein 2
2800 Mechelen · FlandreSee on map
Contributed capital
6 200,02 €
Latest accounts
31/12/2024
Average workforce
331,4 ETP
Joint committees (3)
  • 100
  • 200
  • 218
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 19 filings

Trend over 19 financial years

20242023202220212020
Income statement
Revenue42,5 M €31,4 M €25,9 M €19,7 M €15,6 M €
EBITDA4,6 M €2,6 M €1,7 M €1,3 M €1,1 M €
Operating result4,6 M €2,5 M €1,7 M €1,3 M €1 M €
Net result2,9 M €1,7 M €928,7 k €687,8 k €539 k €
Balance sheet
Equity13,6 M €8,7 M €7 M €6,1 M €5,4 M €
Total assets20,6 M €14,9 M €12,5 M €9,3 M €8 M €
Cash823 k €1,8 M €1,2 M €365,2 k €471,6 k €
Debts7 M €6,2 M €5,5 M €3,2 M €2,7 M €
Other
Workforce331,4 ETP240,7 ETP231,0 ETP199,9 ETP160,6 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 25 M€ and 50 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2024

2 active · 11 ended

Active mandates

Diarmaid Cunningham

Director · since 01 juillet 2021

Active
Joe Cronin

Director · since 01 juillet 2021

Active

Ended mandates

Joe Cronin

Managing director · since 01 juillet 2021

Ended
Robert Leftwich

Director · since 01 juillet 2021

Ended
Chris Gray

Director · since 01 octobre 2011 · until 01 juillet 2021

Ended
Chris Gray

Manager · since 01 octobre 2011

Ended

Other companies at this address

Kardinaal Mercierplein 2 2800 Mechelen
CompanyCBE no.
Administratiekantoor Temmune Therapeutics● Active
1025.942.868
ALL IN ONE DELIVERY● Bankrupt
0691.693.043
Amber Therapeutics Belgium● Active
1042.186.806
Anima● Active
0696.648.852
ANIRES● Active
1016.204.761
AVENO CARGO CENTER● Active
0648.895.257
Bausch + Ströbel Customer Care Center Belgium● Active
0802.924.725
BENELUX & PARTNERS● Active
0764.941.208
BlueStone Underwriting● Active
1042.777.516
C&A ELECTRICITY● Bankrupt
0797.043.258
CaptureAge● Active
0734.747.383
CHARMEWONING● Bankrupt
0826.369.328
Cybercontract● Active
0557.948.651
Delgabre Group● Bankrupt
0739.758.919
ESKENS BENELUX● Active
0439.773.650
Foundation CaptureAge● Active
1015.127.269
FRUTAROM BELGIUM● Active
0403.593.145
HANOVER DISPLAYS● Active
0737.945.118
HERA● Active
0441.391.273
JAMAIS-SANS-TOIT● Active
1005.687.684

Full financial information

Source · NBB
202420232022202120202019
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202401/01/202301/01/202201/01/202101/01/202001/01/2019
Closing of the financial year31/12/202431/12/202331/12/202231/12/202131/12/202031/12/2019
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date10/12/202520/12/202412/07/202408/09/202302/11/202112/11/2020
General meeting05/12/202520/12/202403/06/202416/03/202329/10/202108/09/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 19 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202405/12/202510/12/2025DutchPDF
Full model31/12/202320/12/202420/12/2024DutchPDF
Full model31/12/202203/06/202412/07/2024DutchPDF
Full model31/12/202116/03/202308/09/2023DutchPDF
Full model31/12/202029/10/202102/11/2021DutchPDF
Full model31/12/201908/09/202012/11/2020DutchPDF
Full model31/12/201805/08/201922/10/2019DutchPDF
Full model31/12/201716/08/201828/09/2018DutchPDF
Full model31/12/201606/06/201729/09/2017DutchPDF
Full model31/12/201506/06/201630/09/2016DutchPDF
Full model31/12/201406/06/201528/08/2015DutchPDF
Full model31/12/201328/08/201429/08/2014DutchPDF
Full model31/12/201226/08/201331/08/2013DutchPDF
Full model31/12/201117/07/201231/07/2012DutchPDF
Full model31/12/201021/09/201129/09/2011DutchPDF
Full model31/12/200906/09/201030/09/2010DutchPDF
Full model31/12/200830/06/200908/10/2009DutchPDF
Full model31/12/200706/06/200831/07/2008DutchPDF
Full model31/12/200621/12/200730/01/2008DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 25 M€ and 50 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

2 active · 11 ended

Active mandates

Diarmaid Cunningham

Director · since 01 juillet 2021

Active
Joe Cronin

Director · since 01 juillet 2021

Active

Ended mandates

Joe Cronin

Managing director · since 01 juillet 2021

Ended
Robert Leftwich

Director · since 01 juillet 2021

Ended
Chris Gray

Director · since 01 octobre 2011 · until 01 juillet 2021

Ended
Chris Gray

Manager · since 01 octobre 2011

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates27/05/2026
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates18/06/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates14/10/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office19/02/2024
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Restructuring12/01/2024
    BENAMING - DOEL - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Mandates29/12/2023
    KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
    PDF
  • Restructuring13/11/2023
    RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Mandates05/04/2022
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 20242,9 M €↑
  2. 2023
    Annual accounts 20231,7 M €↑
  3. 2022
    Annual accounts 2022928,7 k €↑
  4. 2022
    Name changeICON Clinical Research Belgium BV
  5. 2021
    Annual accounts 2021687,8 k €↑
  6. 2021
    Name changePharmaceutical Research Associates Belgium
  7. 2020
    Annual accounts 2020539 k €↑
  8. 2019
    Annual accounts 2019469,2 k €↑
  9. 2018
    Annual accounts 2018447,9 k €↑
  10. 2017
    Annual accounts 2017339,4 k €↓
  11. 2016
    Annual accounts 2016346,1 k €↑
  12. 2015
    Annual accounts 2015268,5 k €↓
  13. 2014
    Annual accounts 2014318,7 k €↑
  14. 2013
    Annual accounts 2013279,4 k €↑
  15. 2012
    Annual accounts 2012260 k €↑
  16. 2011
    Annual accounts 2011216,7 k €↑
  17. 2010
    Annual accounts 201053 k €↓
  18. 2009
    Annual accounts 200957,3 k €↑
  19. 2008
    Annual accounts 2008-21,6 k €↓
  20. 2007
    Annual accounts 200733,7 k €↓
  21. 2006
    Annual accounts 200659,1 k €
  22. 08/10/1999
    IncorporationPrivate limited company